Theranostic Nanoparticle Prodrug

Conceptual illustration of novel multifunctional “theranostic” nanoparticles (TNPs) created for enzyme-specific drug activation at tumor sites and simultaneous in vivo magnetic resonance imaging (MRI) of drug delivery. Essentially, these new “smart” NPs selectively kill cancer cells without affecting healthy cells.

These theranostic nanoparticles combine diagnostics and therapeutic properties of superparamagnetic iron oxide NPs and attached to it activatable prodrug respectively. This tumor specific drug release allows to reduce side-effects of cancer therapy. The magnetic core of the nanoparticles allows for monitoring their distribution in the body.

Tools: Illustrator, Photoshop, Blender.